Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in cutaneous sarcoidosis
NCT00690911Phase 2Withdrawn
- Sponsor
- Wake Forest University
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in cutaneous sarcoidosis, sponsored by Wake Forest University. Status: withdrawn.
02
Drugs
03
Conditions
cutaneous sarcoidosis
Beyond the preview
Go deeper on NCT00690911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690911.